CDC: Moderna COVID-19 Vaccine Causes Rare Anaphylactic ShockAHC MEDIAHospital Employee Health
WASHINGTON, Feb. 4 (Xinhua) -- The U.S. Centers for Disease Control and Prevention (CDC) on Friday endorsed recommendation from its vaccine advisers for use of the Moderna COVID-19 vaccine for people ages 18 years and older. The recommendation came after the U.S. Food and Drug Administra...
LOS ANGELES, June 24 (Xinhua) -- Vaccine advisers to the U.S. Centers for Disease Control and Prevention (CDC) voted on Thursday to support recommending the Moderna COVID-19 vaccine for use in people ages 6 through 17 years old. The vaccine received emergency use authorization from the U....
As for recipients of the single-shot J&J vaccine, a COVID-19 booster is recommended for everyone at least two months after their vaccination. That's because the J&J vaccine hasn't proved as protective as the two-dose Moderna or Pfizer options. The CDC panel didn't explicitly recommend...
The Centers for Disease Control and Prevention's outside vaccine advisers voted unanimously Thursday to expand their recommendations for Moderna's COVID-19 vaccine to virtually all ages of children, adding the first alternative to Pfizer's shots for millions of adolescents and school-age kids. On...
The US CDC ACIP voted to recommend the use of Moderna’s Covid-19 vaccine in adults under the Emergency Use Authorisation issued by the FDA.
CDC和ACIP（美国儿科学会）认为，青少年和男性接种后的心脏炎症关联虽罕见，但重要的是要强调，疫苗带来的益处远大于风险。辉瑞和Moderna疫苗将增加相关警示信息。平衡风险与益处 尽管12-17岁男孩每100万剂可能有56-69例心肌炎，但疫苗能显著降低COVID-19的感染率，尤其在高死亡风险的青少年群体中，接种...
美国疾病管制暨预防中心(CDC)今天发布的一份新研究显示,莫德纳(Moderna)COVID-19疫苗在防止住院上,保护力较辉瑞(Pfizer)BNT疫苗持久。 CDC研究人员分析今年3月11日到8月15日近3689名感染COVID-19症状严重的住院成人,这段时间含括后来导致疫情复燃的Delta变异株(最先出现于印度)的流行期。
The Centers for Disease Control and Prevention on Friday continued its endorsement of Moderna's COVID-19 vaccine for adults, now that U.S. regulators have given the shots their full approval.
Several vaccine makers including Pfizer Inc, Moderna Inc and Novavax Inc are testing versions of their COVID vaccines updated to combat the Omicron variant. Pfizer and Moderna have said their new vaccines also appear to work against the subvariants, even though...